Lv1
30 积分 2026-04-13 加入
Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura (HERCULES trial)
5个月前
已完结
IMM20059, A NOVEL ANTI-EPN1 ANTIBODY, IN COMBINATION WITH ATEZOLIZUMAB SIGNIFICANTLY ENHANCES TUMOR REGRESSION IN THE B16.F10 SYNGENEIC MELANOMA MODEL COMPARED TO ANTIPD-L1 MONOTHERAPY
5个月前
已完结
Liposomal doxorubicin targeted with the Fab' of atezolizumab as a novel strategy against HCC
5个月前
已关闭
High-affinity omalizumab variants with optimized disruptive potency prevent anaphylaxis in vivo
5个月前
已完结
皖公网安备34019202002308
